KKR's Rowbottom on Bonds, IPOs, Cancer Research

KKR's Rowbottom on Bonds, IPOs, Cancer Research Play

May 23 (Bloomberg) -- Jeff Rowbottom, managing director and head of capital markets for North America at KKR & Co., talks about the outlook for the high-yield bond market, U.S. equities, and initial public offerings. Rowbottom, speaking with Deirdre Bolton on Bloomberg Television's "Money Moves," also discusses his involvement in the Melanoma Research Alliance and developments in cancer therapy. (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus